162 related articles for article (PubMed ID: 3937578)
1. Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis.
Bell NH; Shary J; Shaw S; Turner RT
Calcif Tissue Int; 1985 Dec; 37(6):588-91. PubMed ID: 3937578
[TBL] [Abstract][Full Text] [Related]
2. Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.
Shigeno C; Yamamoto I; Dokoh S; Hino M; Aoki J; Yamada K; Morita R; Kameyama M; Torizuka K
J Clin Endocrinol Metab; 1985 Oct; 61(4):761-8. PubMed ID: 2993347
[TBL] [Abstract][Full Text] [Related]
3. Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism.
Epstein S; Stern PH; Bell NH; Dowdeswell I; Turner RT
Calcif Tissue Int; 1984 Sep; 36(5):541-4. PubMed ID: 6441625
[TBL] [Abstract][Full Text] [Related]
4. [Circulating metabolites of vitamin D in 14 children with hypercalcemia].
Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927
[TBL] [Abstract][Full Text] [Related]
5. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis.
Gates S; Shary J; Turner RT; Wallach S; Bell NH
J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal synthesis of 1,25-dihydroxyvitamin D and hypercalcemia in children with tuberculosis].
Saggese G; Bertelloni S; Baroncelli GI; Fusaro C; Gualtieri M
Pediatr Med Chir; 1989; 11(5):529-32. PubMed ID: 2631059
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies.
Garabédian M; Jacqz E; Guillozo H; Grimberg R; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
N Engl J Med; 1985 Apr; 312(15):948-52. PubMed ID: 3838365
[TBL] [Abstract][Full Text] [Related]
9. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia in infants with congenital hypothyroidism and its relation to vitamin D and thyroid hormones.
Tau C; Garabedian M; Farriaux JP; Czernichow P; Pomarede R; Balsan S
J Pediatr; 1986 Nov; 109(5):808-14. PubMed ID: 3490559
[TBL] [Abstract][Full Text] [Related]
11. Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia.
Saggese G; Bertelloni S; Baroncelli GI; Di Nero G
Am J Dis Child; 1993 Mar; 147(3):270-3. PubMed ID: 8438806
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D metabolism in idiopathic infantile hypercalcemia.
Aarskog D; Aksnes L; Markestad T
Am J Dis Child; 1981 Nov; 135(11):1021-4. PubMed ID: 6271008
[TBL] [Abstract][Full Text] [Related]
13. The role of vitamin D metabolites in hypercalcemia of Zucker fa/fa rats.
Ishida H; Seino Y; Matsukura S; Ishizuka S; Imura H
J Nutr Sci Vitaminol (Tokyo); 1985 Feb; 31(1):1-5. PubMed ID: 3874938
[TBL] [Abstract][Full Text] [Related]
14. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.
Yamato H; Matsumoto T; Fukumoto S; Ikeda K; Ishizuka S; Ogata E
Endocrinology; 1989 Jan; 124(1):511-7. PubMed ID: 2783309
[TBL] [Abstract][Full Text] [Related]
15. Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man.
Lambert PW; Stern PH; Avioli RC; Brackett NC; Turner RT; Greene A; Fu IY; Bell NH
J Clin Invest; 1982 Mar; 69(3):722-5. PubMed ID: 6895901
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolism in hypoparathyroidism.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
[TBL] [Abstract][Full Text] [Related]
17. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis.
Shaker JL; Redlin KC; Warren GV; Findling JW
Am J Med Sci; 1994 Aug; 308(2):115-8. PubMed ID: 8042652
[TBL] [Abstract][Full Text] [Related]
18. Are tuberculous patients at a great risk from hypercalcemia?
Fuss M; Karmali R; Pepersack T; Bergans A; Dierckx P; Prigogine T; Bergmann P; Corvilain J
Q J Med; 1988 Nov; 69(259):869-78. PubMed ID: 3271334
[TBL] [Abstract][Full Text] [Related]
19. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase.
Karakelides H; Geller JL; Schroeter AL; Chen H; Behn PS; Adams JS; Hewison M; Wermers RA
J Bone Miner Res; 2006 Sep; 21(9):1496-9. PubMed ID: 16939409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]